COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
dNovo develops a proprietary direct reprogramming platform to convert patient-derived skin cells into personalized induced hair stem cells without a pluripotent intermediate, demonstrated hair generation in preclinical mouse models.
